Insulin resistance versus insulin secretion in the hypertension of obesity.
- 1 April 1992
- journal article
- abstracts
- Published by Wolters Kluwer Health in Hypertension
- Vol. 19 (4) , 385-392
- https://doi.org/10.1161/01.hyp.19.4.385
Abstract
We measured the degree of association between obesity, blood pressure, insulin resistance, and insulin secretion in 72 male and female obese hypertensive, obese nonhypertensive, and normal weight control subjects. Baseline weight, body mass index, percent body fat, waist/hip ratio, and systolic and diastolic blood pressures were obtained. Insulin sensitivity was assessed according to Bergman's minimal model. Twelve-hour urinary c-peptide was measured after a standard liquid meal. Insulin action was inversely associated with blood pressure status, obesity status, and age. Meal-stimulated c-peptide excretion significantly correlated with systolic blood pressure and percent fat but not with body mass index or age. Multivariate regression analysis indicated that, of the measures of body composition, percent fat and waist/hip ratio had the strongest correlation with insulin action either alone or in combination with c-peptide excretion. Obese hypertensive patients had an index of insulin action (10(-4).min-1/[microunits/ml]) of 1.34 +/- 0.19, which was significantly (p less than 0.003) lower than in the obese nonhypertensive patients (index, 2.26 +/- 0.10) or the nonobese subjects (index, 5.41 +/- 0.26, p less than 0.001). Meal-stimulated c-peptide excretion (nmol/kg lean body mass) was increased only in the obese hypertensive group (0.32 +/- 0.01) and was significantly higher (p less than 0.001) than in the obese nonhypertensive (0.16 +/- 0.01) or the nonobese subjects (0.14 +/- 0.01). These results support the hypothesis that abnormalities in blood pressure regulation, insulin-stimulated glucose uptake, and insulin secretion coexist.Keywords
This publication has 34 references indexed in Scilit:
- A Comparison of the Effects of Hydrochlorothiazide and Captopril on Glucose and Lipid Metabolism in Patients with HypertensionNew England Journal of Medicine, 1989
- Reversibility of defective adipocyte insulin receptor kinase activity in non-insulin-dependent diabetes mellitus. Effect of weight loss.Journal of Clinical Investigation, 1988
- Role of glucose transporters in the cellular insulin resistance of type II non-insulin-dependent diabetes mellitus.Journal of Clinical Investigation, 1988
- Insulin and blood pressure during weight loss in obese adolescents.Hypertension, 1987
- Insulin and Hypertension: Lessons from ObesityNew England Journal of Medicine, 1987
- Insulin Resistance in Essential HypertensionNew England Journal of Medicine, 1987
- Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp.Journal of Clinical Investigation, 1987
- Studies on the mechanism of insulin resistance in the liver from humans with noninsulin-dependent diabetes. Insulin action and binding in isolated hepatocytes, insulin receptor structure, and kinase activity.Journal of Clinical Investigation, 1986
- Nonpharmacological approaches to the control of high blood pressure. Final report of the Subcommittee on Nonpharmacological Therapy of the 1984 Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure.Hypertension, 1986
- Relation of weight change to changes in atherogenic traits: The Framingham studyJournal of Chronic Diseases, 1974